During the past decade, Hospital Universitario de Toledo conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Toledo" #1 sponsor was "Castilla-La Mancha Health Service" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Loxo Oncology, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Toledo" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Pierre Fabre Laboratories" with 1 trials as a collaborator and "Puma Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Toledo" are "Chronic Lymphocytic Leukemia" (2 trials), "Small Lymphocytic Lymphoma" (2 trials), "Type 1 Diabetes" (2 trials), "Breast Cancer" (1 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Hospital Universitario de Toledo" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Toledo" are "Drug" (10 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials), "Venetoclax" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Toledo" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario de Toledo". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Universitario de Toledo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Toledo, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".